Rapid screening of small ligand affinity to human serum albumin by an optical biosensor.

Here we report the use of IAsys biosensor technology for determining the binding parameters of low molecular weight compounds, such as warfarin and bilirubin, to surface immobilized human serum albumin. The protein was covalently immobilized on the surface of the biosensor cuvette, bearing a carboxymethyl dextran layer, through a condensing reaction between the carboxyl groups of the biosensor surface and epsilon-amine groups of protein lysine residues. This system detects and quantifies the changes in refractive index in the vicinity of the surface of the sensor chip to which the protein is immobilized. The changes in the refractive index are proportional to the change in the absorbed mass, thus the analysis allows the monitoring of the interaction process and the determination of the binding parameters. Optical biosensor analysis, most suited for studying protein/protein or protein/nucleic acid interactions, was sensitive enough to monitor the binding of low molecular weight compounds to human serum albumin and then suitable for a rapid screening of libraries of potential drugs when bioavailability is the research target.

[1]  Y. Engelborghs,et al.  Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study. , 1982, Molecular pharmacology.

[2]  A. Rosén The measurement of binding constants using circular dichroism. Binding of phenylbutazone and oxyphenbutazone. , 1970, Biochemical pharmacology.

[3]  Gabriela Canziani,et al.  Exploring biomolecular recognition using optical biosensors. , 1999, Methods.

[4]  T. Peters,et al.  All About Albumin: Biochemistry, Genetics, and Medical Applications , 1995 .

[5]  E. Domenici,et al.  Stereochemical features of 1,4-benzodiazepin-2-ones bound to human serum albumin: difference CD and UV studies. , 1990, Chirality.

[6]  C. Bertucci,et al.  Ligand binding to a human serum albumin stationary phase: use of same-drug competition to discriminate pharmacologically relevant interactions. , 1998, Biomedical chromatography : BMC.

[7]  U Kragh-Hansen,et al.  Molecular aspects of ligand binding to serum albumin. , 1981, Pharmacological reviews.

[8]  G. Mudge Cholecystographic agents and drug binding to plasma albumin. , 1980, Investigative radiology.

[9]  R. Rich,et al.  Survey of the 1999 surface plasmon resonance biosensor literature , 2000, Journal of molecular recognition : JMR.

[10]  D. S. Hage,et al.  Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase. , 1992, Journal of chromatography.

[11]  Mike Hoare,et al.  Rapid monitoring of recombinant protein products: a comparison of current technologies. , 2002, Trends in biotechnology.

[12]  D. S. Hage,et al.  High-performance affinity chromatography: a powerful tool for studying serum protein binding. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  W. David Wilson,et al.  Analyzing Biomolecular Interactions , 2002, Science.

[14]  D G Myszka,et al.  High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE. , 2001, Analytical biochemistry.

[15]  E. Domenici,et al.  Synthesis and chromatographic properties of an HPLC chiral stationary phase based upon human serum albumin , 1990 .

[16]  H Roos,et al.  Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. , 2000, Journal of medicinal chemistry.

[17]  Irving W. Wainer,et al.  Enantioselective high-performance liquid affinity chromatography as a probe of ligand-biopolymer interactions: an overview of a different use for high-performance liquid chromatographic chiral stationary phases , 1994 .

[18]  Alex Avdeef,et al.  Physicochemical Profiling (Solubility, Permeability and Charge State) , 2001 .